Modification of the receptor component of adenylate cyclase in the rat brain by phenothiazine derivatives.
D000067956:Adenylyl Cyclase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry / Q000187:drug effects; D002540:Cerebral Cortex / Q000378:metabolism; D002746:Chlorpromazine / Q000031:analogs & derivatives / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D005476:Fluphenazine / Q000031:analogs & derivatives / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006900:Hydroxylation; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010546:Perphenazine / Q000031:analogs & derivatives / Q000494:pharmacology; D011346:Prochlorperazine / Q000031:analogs & derivatives / Q000494:pharmacology; D011395:Promazine / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013888:Thiothixene / Q000494:pharmacology; D014316:Tritium
D000067956:Adenylyl Cyclase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D011955:Receptors, Drug; D014316:Tritium; D013888:Thiothixene; D000242:Cyclic AMP; D010546:Perphenazine; D006220:Haloperidol; D011395:Promazine; D005476:Fluphenazine; D002746:Chlorpromazine; D009638:Norepinephrine; D011346:Prochlorperazine